ロード中...
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...
保存先:
主要な著者: | , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
MDPI AG
2020-10-01
|
シリーズ: | Cancers |
主題: | |
オンライン・アクセス: | https://www.mdpi.com/2072-6694/12/10/2993 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|